Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06WKA
|
|||
| Former ID |
DCL000878
|
|||
| Drug Name |
MD-1100
|
|||
| Synonyms |
Linaclotide acetate; Linaclotide acetate (USAN); MM-416775
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Constipation [ICD-11: DD91.1; ICD-10: K59.0; ICD-9: 564] | Approved | [1] | |
| Irritable bowel syndrome [ICD-11: DD91.0; ICD-10: K55-K64, K58; ICD-9: 564.1, 787.91] | Phase 2 | [2] | ||
| Company |
Microbia
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C61H83N15O23S6
|
|||
| Canonical SMILES |
CC1C(=O)NC2CSSCC3C(=O)NC(C(=O)NC(C(=O)NC(CSSCC(NC(=O)CNC(=O)C(NC2=O)C(C)O)C(=O)NC(CC4=CC=C(C=C4)O)C(=O)O)C(=O)NC(CSSCC(C(=O)N3)N)C(=O)NC(C(=O)N5CCCC5C(=O)N1)CC(=O)N)CC6=CC=C(C=C6)O)CCC(=O)O.CC(=O)O
|
|||
| InChI |
1S/C59H79N15O21S6.C2H4O2/c1-26-47(82)69-41-25-101-99-22-38-52(87)65-33(13-14-45(80)81)49(84)66-34(16-28-5-9-30(76)10-6-28)50(85)71-40(54(89)72-39(23-97-96-20-32(60)48(83)70-38)53(88)67-35(18-43(61)78)58(93)74-15-3-4-42(74)56(91)63-26)24-100-98-21-37(64-44(79)19-62-57(92)46(27(2)75)73-55(41)90)51(86)68-36(59(94)95)17-29-7-11-31(77)12-8-29;1-2(3)4/h5-12,26-27,32-42,46,75-77H,3-4,13-25,60H2,1-2H3,(H2,61,78)(H,62,92)(H,63,91)(H,64,79)(H,65,87)(H,66,84)(H,67,88)(H,68,86)(H,69,82)(H,70,83)(H,71,85)(H,72,89)(H,73,90)(H,80,81)(H,94,95);1H3,(H,3,4)/t26-,27+,32-,33-,34-,35-,36-,37-,38-,39-,40-,41-,42-,46-;/m0./s1
|
|||
| InChIKey |
KWFNVZFWXXEJKL-YZDVLOIKSA-N
|
|||
| CAS Number |
CAS 851199-60-5
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| SuperDrug ATC ID |
A06AX04
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Guanylyl cyclase C (GUCY2C) | Target Info | Activator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Nat Rev Drug Discov. 2013 Feb;12(2):87-90. | |||
| REF 2 | Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs. 2006 May;11(2):293-313. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.